View All Cardiology Activities Featured Cardio Activities

		Stephen D. Wiviott, MD presents... Optimizing Antiplatelet Therapy in the ACS Patient: Limitations of Current Antiplatelet Therapy in ACS and PCI and Potential Solutions Released: February 28, 2008 Expires: February 28, 2009	0.50CME

		Deepak L. Bhatt, MD, FACC, FAHA presents... Optimizing Antiplatelet Therapy in the ACS Patient: The Intersection of Acute Coronary Syndromes and Oral Antiplatelet Therapy Released: February 28, 2008 Expires: February 28, 2009	0.50CME

		James M. Atkins, MD and colleagues present... Understanding the Evidence: The Role of Medication Management and Coronary Intervention in UA/NSTEMI Released: June 2, 2008 Expires: June 2, 2009	1.00CME 1.00CPE

		Elliott M. Antman, MD, FACC presents... Optimizing Antiplatelet Therapy in the ACS Patient: Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel Released: February 28, 2008 Expires: February 28, 2009	1.00CME

		Paul M. Ridker, MD, MPH, FACC, FAHA presents... Pathology and Treatment of Rheumatoid Arthritis: Systematic Inflammation and Cardiovascular Risk: Relevance to Rheumatoid Arthritis Released: February 19, 2008 Expires: February 19, 2009	0.50CME 0.50CPE 0.50CNE

Feed Provided by MedWorm.com Cardio News

View All Events Cardio Events

a.
Society for Cardiovascular Angiography and Interventions
40th Annual Cardiovascular Conference at Snowmass
b.
The Society of Thoracic Surgeons
45th Annual Meeting
c.
American College of Cardiology
3rd Annual The Heart of Women�s Health
d.
American College of Cardiology
Peripheral Arterial Disease: Key Components for Cardiovascular Specialists
e.
American College of Cardiology
31st Annual Cardiology at Big Sky

Pathology and Treatment of Rheumatoid Arthritis: Systematic Inflammation and Cardiovascular Risk: Relevance to Rheumatoid Arthritis

0.50CME

0.50CPE

0.50CNE

Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of... Read More

Presented By
Paul M. Ridker, MD, MPH, FACC, FAHA

Eugene Braunwald Professor of Medicine, Harvard Medical School
Director, Center for...
View Other CE